JPRN-jRCT2080221738未知3 期
ong-term study on combinational therapy of SMP-508 with dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus
Sumitomo Dainippon Pharma Co.,Ltd.0 个研究点目标入组 80 人开始时间: 2012年3月9日最近更新:
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with type 2 diabetes mellitus who meet the following requirements
- •-Patients who have been on a fixed regimen of diet and exercise therapies
- •-Patients who have been taking sitagliptin continuously at a fixed dose
- •-Patients whose HbA1c level is 6.9% <= HbA1c (NGSP) <= 9.4% and is stable over 4 weeks
- •-Patients aged 20 or older
- •-Outpatients
排除标准
- •-Patients with hepatic dysfunction
- •-Patients with renal dysfunction
- •-Patients with cardiac diseases
- •-Patients with severe hypertension
研究者
相似试验
未知
3 期
ong-term study on combinational therapy of SMP-508 with pioglitazone in patients with type 2 diabetes mellitusType 2 diabetes mellitus whose blood glucose levels are not adequately controlled by pioglitazone in addition to diet and exercise therapiesJPRN-jRCT2080221169Dainippon Sumitomo Pharma Co., Ltd.120
未知
3 期
ong-term study on combinational therapy of SMP-508 with metformin in patients with type 2 diabetes mellitusType 2 diabetes mellitus whose blood glucose levels are not adequately controlled by metformin in addition to diet and exercise therapiesJPRN-jRCT2080221167Dainippon Sumitomo Pharma Co., Ltd.120
未知
3 期
Phase 3 study on combinational therapy of SMP-508 with metformin in patients with type 2 diabetes mellitusJPRN-jRCT2080221166Dainippon Sumitomo Pharma Co., Ltd.120
未知
3 期
Phase 3 study on combinational therapy of SMP-508 with pioglitazone in patients with type 2 diabetes mellitusType 2 diabetes mellitus patients whose blood glucose levels are not adequately controlled by pioglitazone in addition to diet and exercise therapiesJPRN-jRCT2080221168Dainippon Sumitomo Pharma Co., Ltd.120
已完成
3 期
Efficacy of Pentoxifylline in diabetic nephropathyCondition 1: Type 2 Diabetes. Condition 2: Diabetic Nephropathy.Type 2 diabetes mellitus????????? ????????N00-N08IRCT20190806044451N2Zanjan University of Medical Sciences60